A service of StreetInsider.com
Welcome

Most Popular

AAPL 197.11
C 3.20
GOOG 540.00
BAC 14.56
RIMM 66.65

Recently Added

DANA 0.20
OWVI 0.00
IDC 29.11
WCH 0.15
SEWE 0.90

Gaining Speed

CTGI 0.13
MKSI 18.62
HLXW 1.48
ISCO 1.36
WLCDF 1.63
8.16 +0.04 (0.48%) MITI

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:8.16 Change:+0.04 (0.48%) Prev Close:8.12 Open: 8.26 Days Range:8.02 – 8.26 52 Week Range: 2.25 - 8.48 Volume:218923 P/E: N/A
EPS:-0.70

Member Comments

No member comments available for MITI


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 02/09/10

Recent Alert on 02/04/10 at 7:41am
Roth Capital Upgrades Micromet (MITI) to Buy

Roth Capital upgrades Micromet (Nasdaq: MITI) from Hold to Buy. Price target increased to $12. To see all the upgrades/downgrades on shares of MITI, visit our Analyst Ratings page. Micromet, Inc. (Micromet) is a biopharmaceutical company developing... Read More

Recent Alert on 01/25/10 at 9:14am
Needham & Co Initiates Coverage on Micromet (MITI) with a Buy
Recent Alert on 12/09/09 at 7:40am
Roth Capital Downgrades Micromet (MITI) to Hold; Valuation Call
Recent Alert on 12/07/09 at 8:17am
Micromet (MITI) Annouces Phase I Publication of Blinatumomab for NHL
Recent Alert on 12/07/09 at 8:17am
Micromet (MITI) Annouces Phase I Publication of Blinatumomab for NHL

View AllRecent Press Releases

No Recent Press Releases Available

View AllRecent SEC Filings

SEC Filing on 02/05/10 at 4:06pm
Form 8-K MICROMET, INC. For: Feb 04

View AllRecent Blog Posts

Blog Posts on 01/17/10 at 9:57am
The Future of Biotech: Party Like It's 1999
Blog Posts on 12/31/09 at 8:40am
Micromet's BiTE Pipeline Impresses
Blog Posts on 12/16/09 at 10:58am
Micromet: Opportunity Lies in Breakthrough BiTE Antibody
Blog Posts on 12/02/09 at 11:45am
Analyst upgrades, downgrades and initiations: DOLE, DWA, ESRX, FOSL, GIL, HR, STZ ...
Blog Posts on 12/02/09 at 7:46am
Immunogen's Busy Month, Part II